Company Description
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally.
It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile.
The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors.
Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
| Country | United States |
| Founded | 1901 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| CEO | Timothy Wentworth |
Contact Details
Address: 108 Wilmot Road Deerfield, Illinois 60015 United States | |
| Phone | 847 315 3700 |
| Website | walgreensbootsalliance.com |
Stock Details
| Ticker Symbol | WBA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| CIK Code | 0001618921 |
| CUSIP Number | 931427108 |
| ISIN Number | US9314271084 |
| Employer ID | 47-1758322 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Timothy C. Wentworth | Chief Executive Officer and Director |
| Stefano Pessina | Executive Chairman of the Board |
| Manmohan Mahajan | Executive Vice President and Global Chief Financial Officer |
| Ornella Barra | Chief Operating Officer of International |
| Mary Langowski | Executive Vice President and President of Walgreens Health |
| Todd D. Heckman | Senior Vice President, Global Controller and Chief Accounting Officer |
| Dr. Neal Joseph Sample Ph.D. | Executive Vice President and Chief Information Officer |
| Matthew D'Ambrosio | Senior Vice President and Global Chief Compliance and Ethics Officer |
| Lanesha T. Minnix J.D. | Executive Vice President and Global Chief Legal Officer, Secretary |
| Elizabeth L. Burger | Executive Vice President and Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2025 | 8-K | Current Report |
| Jul 11, 2025 | SC 13E3/A | [Amend] Going private transaction by certain issuers |
| Jul 11, 2025 | 8-K | Current Report |
| Jul 3, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 3, 2025 | 8-K | Current Report |
| Jun 26, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 26, 2025 | 10-Q | Quarterly Report |
| Jun 26, 2025 | 8-K | Current Report |
| Jun 17, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 13, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |